Summer Haven Investment Management, LLC United Therapeutics Corp Transaction History

Summer Haven Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$179.86 - $214.88 $650,553 - $777,220	-3,617 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$170.47 - $211.93 $15,342 - $19,073	90 Added 2.55%	3,617 $649,000
Q4 2020 Feb 17, 2021	SELL	$101.87 - $151.79 $54.2 Million - $80.7 Million	-531,836 Reduced 99.34%	3,527 $535,000
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $54.5 Million - $81.3 Million	535,363 New	535,363 $535,000

561

43.1M

501K

529K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Summer Haven Investment Management, LLC with notifications on news.